blood pressure medication

Vivimed Life Sciences has recalled Losartan Potassium Tablets USP due to higher levels of a possible carcinogen than the Food and Drug Administration allows.

Another company has expanded its recall of a prescription drug used to treat high blood pressure and congestive heart failure, marking the latest in a series of nearly two dozen recalls sweeping the country since last summer.

A multibillion-dollar pharmaceutical company has expanded its national recall of a prescription drug used to treat high blood pressure and congestive heart failure for the fourth time since December after trace amount of a possible carcinogen were detected, federal officials announced Thursday.

Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About 56,000 bottles of losartan tablets were recalled by Camber Pharmaceuticals on Thursday, the latest in a series of losartan-related recalls. No one has reported any adverse affects from the drug...

The head of the U.S. Food and Drug Administration says the agency has launched a “major operation to investigate and address” the “troubling” finding of a cancer-causing agent that may be contaminating a growing number of medications used to treat high blood pressure and heart failure.